Downregulation of PDIA3 inhibits proliferation and promotes apoptosis, making it a novel therapeutic target for colorectal cancer (CRC) and acute myeloid leukemia (AML) (24, 25). The gene discussed is PDIA3; the disease is acute myeloid leukemia.